{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:02:12Z","timestamp":1783702932950,"version":"3.55.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Many patient-reported outcomes (PROs) have been developed for inflammatory bowel disease (IBD) without recommendations for clinical use. PROs differ from physician-reported disease activity indices; they assess patients\u2019 perceptions of their symptoms, functional status, mental health, and quality of life, among other areas. We sought to investigate the current global use and barriers to using PROs in clinical practice for IBD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A cross-sectional survey was performed. An electronic questionnaire was sent to an international group of providers who care for patients with IBD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There were 194 respondents, including adult\/pediatric gastroenterologists, advanced practice providers, and colorectal surgeons from 5 continents. The majority (80%) use PROs in clinical practice, 65% frequently found value in routine use, and 50% frequently found PROs influenced management. Thirty-one different PROs for IBD were reportedly used. Barriers included not being familiar with PROs, not knowing how to incorporate PRO results into clinical practice, lack of electronic medical record integration, and time constraints. Most (91%) agreed it would be beneficial to have an accepted set of consistently used PROs. The majority (60%) thought that there should be some cultural differences in PROs used globally but that PROs for IBD should be consistent around the world.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>PROs are used frequently in clinical practice with wide variation in which are used and how they influence management. Education about PROs and how to use and interpret an accepted set of PROs would decrease barriers for use and allow for global harmonization.<\/jats:p><\/jats:sec>","DOI":"10.1093\/crocol\/otad006","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T05:59:03Z","timestamp":1677045543000},"source":"Crossref","is-referenced-by-count":16,"title":["The Real-World Global Use of Patient-Reported Outcomes for the Care of Patients With Inflammatory Bowel Disease"],"prefix":"10.1093","volume":"5","author":[{"given":"Jamie M","family":"Horrigan","sequence":"first","affiliation":[{"name":"Inflammatory Bowel Disease Center, Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center , Lebanon, New Hampshire , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Louis","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, CHU Li\u00e8ge University Hospital , Li\u00e8ge , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Spinelli","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, IRCCS Humanitas Research Hospital , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Travis","sequence":"additional","affiliation":[{"name":"Kennedy Institute of Rheumatology, Translational Gastroenterology Unit, and Biomedical Research Centre, University of Oxford , Oxford , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjorn","family":"Moum","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Oslo University Hospital, Institute of Clinical Medicine, University of Oslo , Oslo , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Salwen-Deremer","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Center, Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center , Lebanon, New Hampshire , USA"},{"name":"Department of Psychiatry, Section of Gastroenterology & Hepatology, Dartmouth-Hitchcock Medical Center , Lebanon, New Hampshire , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Halfvarson","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine and Health, \u00d6rebro University , \u00d6rebro , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remo","family":"Panaccione","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Calgary , Calgary, Alberta , Canada"},{"name":"Department of Community Health Sciences, University of Calgary , Calgary, Alberta , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marla C","family":"Dubinsky","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Susan and Leonard Feinstein IBD Center, Icahn School of Medicine , Mount Sinai, New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Munkholm","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, North Zealand Hospital, University of Copenhagen , Hiller\u00f8d , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2240-6605","authenticated-orcid":false,"given":"Corey A","family":"Siegel","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Center, Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center , Lebanon, New Hampshire , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,2,22]]},"reference":[{"issue":"6","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/bjd.12406","article-title":"Patient-reported outcome measures in skin cancer","volume":"168","author":"Black","year":"2013","journal-title":"Br J Dermatol."},{"key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"614653","DOI":"10.3389\/fimmu.2021.614653","article-title":"Patient reported outcomes in chronic inflammatory diseases: current state, limitations and perspectives","volume":"12","author":"Tran","year":"2021","journal-title":"Front Immunol."},{"issue":"8","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.cgh.2014.02.016","article-title":"Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease","volume":"12","author":"Williet","year":"2014","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1111\/j.1524-4733.2007.00267.x","article-title":"The Mayo Clinic manuscript series relative to the discussion, dissemination, and operationalization of the Food and Drug Administration guidance on patient-reported outcomes","volume":"10","author":"Sloan","year":"2007","journal-title":"Value Health."},{"issue":"1","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11136-008-9413-7","article-title":"Using patient-reported outcomes in clinical practice: challenges and opportunities","volume":"18","author":"Lohr","year":"2009","journal-title":"Qual Life Res."},{"issue":"2","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5056\/jnm.2013.19.2.137","article-title":"Patient-reported outcomes in gastroenterology: clinical and research applications","volume":"19","author":"Spiegel","year":"2013","journal-title":"J Neurogastroenterol Motil."},{"issue":"1","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ibd.21028","article-title":"Quality of care in inflammatory bowel disease: a review and discussion","volume":"16","author":"Kappelman","year":"2009","journal-title":"Inflamm Bowel Dis."},{"issue":"3","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/ecco-jcc\/jjab142","article-title":"Identifying and predicting the goals and concerns prioritised by individuals with inflammatory bowel disease","volume":"16","author":"Tse","year":"2022","journal-title":"J Crohns Colitis."},{"issue":"12","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1093\/ecco-jcc\/jjac099","article-title":"Patient reported outcomes: the ICHOM Standard Set for inflammatory bowel disease in real life practice helps quantify deficits in current care","volume":"16","author":"Wong","year":"2022","journal-title":"J Crohns Colitis."},{"issue":"3","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ecco-jcc\/jjv218","article-title":"Self-reported symptom burden in individuals with inflammatory bowel disease","volume":"10","author":"Farrell","year":"2016","journal-title":"J Crohns Colitis."},{"issue":"6","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/S0002-9270(01)02440-6","article-title":"Concerns of patients with inflammatory bowel disease: results from a clinical population","volume":"96","author":"de Rooy","year":"2001","journal-title":"Am J Gastroenterol."},{"issue":"4","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41575-018-0091-9","article-title":"Fatigue in IBD: epidemiology, pathophysiology and management","volume":"16","author":"Borren","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"18","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.3390\/jcm10184107","article-title":"Prevalence of fatigue and unrecognized depression in patients with inflammatory bowel disease in remission under immunosuppressants and biologicals.","volume":"10","author":"Truyens","year":"2021","journal-title":"J Clin Med."},{"issue":"4","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/ibd\/izx100","article-title":"Quality of life in inflammatory bowel disease: a systematic review and meta-analyses\u2014Part I.","volume":"24","author":"Knowles","year":"2018","journal-title":"Inflamm Bowel Dis."},{"issue":"10","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.crohns.2014.03.005","article-title":"IBD and health-related quality of life\u2014discovering the true impact","volume":"8","author":"Lonnfors","year":"2014","journal-title":"J Crohns Colitis."},{"issue":"5","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.cgh.2017.10.019","article-title":"Patient-reported outcome measures for use in clinical trials and clinical practice in inflammatory bowel diseases: a systematic review","volume":"16","author":"de Jong","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"10","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1111\/j.1572-0241.2001.04682.x","article-title":"The short inflammatory bowel disease questionnaire is reliable and responsive to clinically important change in ulcerative colitis","volume":"96","author":"Jowett","year":"2001","journal-title":"Am J Gastroenterol."},{"issue":"1","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12876-020-01246-7","article-title":"Protocol of a multicentric prospective cohort study for the VALIDation of the IBD-disk instrument for assessing disability in inflammatory bowel diseases: the VALIDate study","volume":"20","author":"Le Berre","year":"2020","journal-title":"BMC Gastroenterol."},{"issue":"4","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/MIB.0000000000000324","article-title":"Short health scale: a valid, reliable, and responsive measure of health-related quality of life in children with inflammatory bowel disease","volume":"21","author":"Abdovic","year":"2015","journal-title":"Inflamm Bowel Dis."},{"issue":"1","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11136-018-2003-4","article-title":"Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn\u2019s disease","volume":"28","author":"Rencz","year":"2019","journal-title":"Qual Life Res."},{"issue":"7","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/ibd.21520","article-title":"Disease activity, behavioral dysfunction, and health-related quality of life in adolescents with inflammatory bowel disease","volume":"17","author":"Gray","year":"2011","journal-title":"Inflamm Bowel Dis."},{"issue":"4","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/ecco-jcc\/jjx161","article-title":"Developing a Standard Set of patient-centred outcomes for inflammatory bowel disease\u2014an international, cross-disciplinary consensus","volume":"12","author":"Kim","year":"2018","journal-title":"J Crohns Colitis."},{"issue":"13","key":"2023031716431584400_","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18137159","article-title":"Role of quality of life as endpoint for inflammatory bowel disease treatment.","volume":"18","author":"Calvino-Suarez","year":"2021","journal-title":"Int J Environ Res Public Health."},{"issue":"7","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/gutjnl-2013-305600","article-title":"Development and validation of a rapid, generic measure of disease control from the patient\u2019s perspective: the IBD-control questionnaire","volume":"63","author":"Bodger","year":"2014","journal-title":"Gut."},{"issue":"5","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1177\/1553350621998871","article-title":"Patient-reported outcome measures in colorectal surgery: construction of core measures using open-source research method","volume":"28","author":"El-Hussuna","year":"2021","journal-title":"Surg Innov."},{"issue":"4","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/1457496918772362","article-title":"Health-related quality of life after restorative proctocolectomy: a cross-sectional study","volume":"107","author":"Helavirta","year":"2018","journal-title":"Scand J Surg."},{"issue":"5","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/ibd.20826","article-title":"Assessing the activity of perianal Crohn\u2019s disease: comparison of clinical indices and computer-assisted anal ultrasound","volume":"15","author":"Losco","year":"2009","journal-title":"Inflamm Bowel Dis."},{"issue":"3","key":"2023031716431584400_","first-page":"317","article-title":"Validation of a novel integral disease index for evaluating the grade of activity in Mexican patients with ulcerative colitis: a prospective cohort study [Validacion de un nuevo indice integral de enfermedad para evaluar el grado de actividad en pacientes mexicanos con colitis ulcerosa: un estudio de cohorte prospectivo]","volume":"84","author":"Yamamoto-Furusho","year":"2019","journal-title":"Rev Gastroenterol Mex (Engl Ed)."},{"issue":"8","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/ibd\/izaa349","article-title":"The relationship between symptoms of depression and anxiety and disease activity in IBD over time","volume":"27","author":"Marrie","year":"2021","journal-title":"Inflamm Bowel Dis."},{"issue":"2","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/gidisord3020007","article-title":"Overview of self-management skills and associated assessment tools for children with inflammatory bowel disease","volume":"3","author":"Vernon-Roberts","year":"2021","journal-title":"Gastrointest Disord."},{"issue":"6","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s10350-004-6652-8","article-title":"Modified pouchitis disease activity index: a simplified approach to the diagnosis of pouchitis","volume":"46","author":"Shen","year":"2003","journal-title":"Dis Colon Rectum."},{"issue":"3","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/ibd\/izab091","article-title":"Development of balanced whole system value measures for inflammatory bowel disease care in the IBD Qorus collaborative using a modified Delphi process","volume":"28","author":"Oliver","year":"2022","journal-title":"Inflamm Bowel Dis."},{"issue":"11\u201312","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/j.1365-2036.2011.04871.x","article-title":"Validation of the functional assessment of chronic illness therapy-fatigue (FACIT-F) in patients with inflammatory bowel disease.","volume":"34","author":"Tinsley","year":"2011","journal-title":"Aliment Pharmacol Ther."},{"issue":"1","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s41687-018-0088-8","article-title":"Psychometric validation of the work productivity and activity impairment questionnaire in ulcerative colitis: results from a systematic literature review","volume":"2","author":"Yarlas","year":"2018","journal-title":"J Patient Rep Outcomes."},{"issue":"2","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/00365521.2020.1857430","article-title":"Cross-cultural translation and validation of the IBD-control questionnaire in The Netherlands: a patient-reported outcome measure in inflammatory bowel disease","volume":"56","author":"de Jong","year":"2021","journal-title":"Scand J Gastroenterol."},{"issue":"1","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12876-020-1164-0","article-title":"The association between disease activity and patient-reported outcomes in patients with moderate-to-severe ulcerative colitis in the United States and Europe","volume":"20","author":"Armuzzi","year":"2020","journal-title":"BMC Gastroenterol."},{"issue":"3","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/ibd\/izaa083","article-title":"Responsiveness of the Patient-reported Outcomes Measurement Information System (PROMIS) pediatric measures to changes in disease status and quality of life among children and adolescents with Crohn\u2019s disease","volume":"27","author":"Brenner","year":"2021","journal-title":"Inflamm Bowel Dis."},{"issue":"2","key":"2023031716431584400_","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/gastroent12020020","article-title":"Patient-reported outcomes in inflammatory bowel disease: a measurement of effect in research and clinical care","volume":"12","author":"Fletcher","year":"2021","journal-title":"Gastroenterology Insights."}],"container-title":["Crohn's &amp; Colitis 360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/advance-article-pdf\/doi\/10.1093\/crocol\/otad006\/49289615\/otad006.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article-pdf\/5\/2\/otad006\/49554188\/otad006.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article-pdf\/5\/2\/otad006\/49554188\/otad006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T01:46:28Z","timestamp":1679795188000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article\/doi\/10.1093\/crocol\/otad006\/7050019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,22]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/crocol\/otad006","relation":{},"ISSN":["2631-827X"],"issn-type":[{"value":"2631-827X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4,1]]},"published":{"date-parts":[[2023,2,22]]},"article-number":"otad006"}}